PD-L1 has been observed translocating from the cell surface to the nucleus of breast cancer cells following doxorubicin therapy.21 Preliminary studies from our laboratory have revealed the overexpression of PD-L1 and its presence in the nucleus of chemoresistant JHU006 human HNSCC cells following cisplatin treatment. This evidence concerns the gene CD274 and breast cancer.